|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2003-11-4
|
|
pubmed:abstractText |
Plasminogen activator inhibitor-1 (PAI-1) has been proposed as a candidate risk factor for restenosis after coronary artery stenting. Transcription, level, and activity of PAI-1 are influenced by the 4G/5G polymorphism in the promoter region of PAI-1 gene. The polymorphism may therefore affect wound-healing processes in injured blood vessels and influence restenosis.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1097-6744
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
146
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
855-61
|
|
pubmed:dateRevised |
2008-11-21
|
|
pubmed:meshHeading |
pubmed-meshheading:14597935-Coronary Angiography,
pubmed-meshheading:14597935-Coronary Disease,
pubmed-meshheading:14597935-Coronary Restenosis,
pubmed-meshheading:14597935-Female,
pubmed-meshheading:14597935-Follow-Up Studies,
pubmed-meshheading:14597935-Genotype,
pubmed-meshheading:14597935-Germany,
pubmed-meshheading:14597935-Humans,
pubmed-meshheading:14597935-Male,
pubmed-meshheading:14597935-Middle Aged,
pubmed-meshheading:14597935-Plasminogen Activator Inhibitor 1,
pubmed-meshheading:14597935-Polymorphism, Genetic,
pubmed-meshheading:14597935-Promoter Regions, Genetic,
pubmed-meshheading:14597935-Stents,
pubmed-meshheading:14597935-Survival Rate,
pubmed-meshheading:14597935-Treatment Outcome,
pubmed-meshheading:14597935-Wound Healing
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
4G/5G polymorphism of the plasminogen activator inhibitor-1 gene and risk of restenosis after coronary artery stenting.
|
|
pubmed:affiliation |
Deutsches Herzzentrum München and 1. Medizinische Klinik rechts der Isar, Technische Universität München, München, Germany. boettiger@dhm.mhn.de
|
|
pubmed:publicationType |
Journal Article
|
